Stereotaxis, Inc. will be showcasing the interventional cardiology capabilities of its Niobe® Magnetic Navigation System at the Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington D.C. on October 20 to 25, 2007

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. Demonstrations in Stereotaxis' Mobile Vascular Lab, the presentation of new clinical data and a live case presentation will underscore the simplicity, safety and precision that Stereotaxis can bring to a variety of vascular interventions.  The Stereotaxis system utilizes advanced, magnet-guided navigational technology designed to help interventional cardiologists perform interventional procedures with enhanced safety and precision. With systems installed at more than 70 leading hospitals worldwide, physicians have used the Stereotaxis system to perform over 2,000 percutaneous coronary interventions (PCI) and other guide wire-based vascular procedures, as well as more than 8,000 complex electrophysiology mapping and ablation procedures, on the left and right sides of the heart.

Stereotaxis' Mobile Vascular Lab will be open for the duration of TCT in booth 8093. Company representatives will be on hand to demonstrate the Niobe system's advanced coronary and peripheral navigation capabilities. Powerful, easy-to-use technologies such as CTO vessel road mapping, image integration and global connectivity capabilities of Odyssey(TM) Network Solutions will also be showcased in the Mobile Vascular Lab.